Figure 1From: Therapeutic algorithms for chronic hepatitis C in the DAA era during the current economic crisis: whom to treat? How to treat? When to treat?Drug costs (in 2011 euros) and effectiveness evaluated as sustained virologic response. Each symbol represents drug costs versus the proportion of patients who achieve SVR among the competing strategies. (See, CammĂ C, et al. Hepatology 2012;56:850-860).Back to article page